Description:
Serlopitant is a Neurokinin 1 (NK-1) receptor antagonist. Phase II clinical trials for the treatment of Prurigo nodularis and Pruritus are ongoing.
- Molecular Weight:555.53
- Purity:98%
Molecular Formula:
C29H28F7NO2
Canonical SMILES:
CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2CCC3CN(CC3C2C4=CC=C(C=C4)F)C5=CC(=O)CC5
InChI:
InChI=1S/C29H28F7NO2/c1-16(19-10-20(28(31,32)33)12-21(11-19)29(34,35)36)39-26-9-4-18-14-37(23-7-8-24(38)13-23)15-25(18)27(26)17-2-5-22(30)6-3-17/h2-3,5-6,10-13,16,18,25-27H,4,7-9,14-15H2,1H3/t16-,18-,25-,26+,27+/m1/s1
InChIKey:
FLNYCRJBCNNHRH-OIYLJQICSA-N
Solubility:
Soluble in DMSO
Appearance:
Powder
Application:
Prurigo nodularis; Pruritus
Storage: -20℃ Freezer
Synonyms:
VPD-737; VPD737; VPD 737; MK-0594; MK 0594; MK0594; 3-((3aR,4R,5S,7aS)-5-((1R)-1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-4-(4 fluorophenyl)octahydro-2H-isoindol-2-yl)cyclopent-2-en-1-one Weitere Informationen finden Sie
hier